HALOZYME THERAPEUTICS INC
HALOZYME THERAPEUTICS INC (HTI) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 398 transactions totaling $44.8M, demonstrating a bullish sentiment with $36.8M in net insider flow. The most recent transaction on Sep 17, 2007 involved a purchase of 238,020 shares valued at $2.1M.
HTI Insider Activity Summary
Who Is Buying HTI Stock?
No significant insider buying has been recorded for HTI in the recent period.
Who Is Selling HTI Stock?
No significant insider selling has been recorded for HTI in the recent period.
Is HALOZYME THERAPEUTICS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for HTI is bullish with an Insider Alignment Score of 91/100 and a net flow of $36.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
HTI Frequently Asked Questions
Understanding HTI Insider Activity
Insider trading at HALOZYME THERAPEUTICS INC (HTI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading HTI stock, having executed 398 transactions in the past 90 days. The most active insider is Randal J. Kirk (Executive), who has made 29 transactions totaling $40.9M.
Related Tools
Track HALOZYME THERAPEUTICS INC Insider Activity
Get notified when executives and directors at HTI file new Form 4 transactions